EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression

Long Teng, Ling Luo, Yanhong Sun, Wei Wang iD, Zhi Dong, Xiaopei Cao iD, Junzhao Ye, Bihui Zhong iD

Nutrients · 2024

DOI: 10.3390/nu17010152 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Nutrients, 2024. Verfasst von Long Teng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, C…. Hauptthemen laut MEDLINE: Blood Glucose, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 1-h post-load plasma glucose was proposed to replace the current OGTT criteria for diagnosing prediabetes/diabetes. However, it remains unclear whether it is superior in identifying progressive metabolic dysfunction-associated steatotic liver disease (MASLD), and thus we aimed to clarify this issue.

Methods

Consecutive Asian participants (non-MASLD, n = 1049; MASLD, n = 1165) were retrospectively enrolled between June 2012 and June 2024. CT was used to quantify liver steatosis, while the serum liver fibrotic marker was used to evaluate liver fibrosis.

Results

Compared with those with normal levels of both 1-h post-glucose (1hPG) and 2-h post-glucose (2hPG), patients with MASLD showed a significant positive association between elevated 1hPG levels and moderate to severe liver steatosis (odds ratio [OR] = 2.19, 95% confidence interval [CI]: 1.13–4.25, p = 0.02]. Elevated levels of both 1hPG and 2hPG were associated with an increased risk of liver injury (OR = 2.03, 95% CI: 1.44–2.86, p < 0.001). Elevated 2hPG levels with or without elevated 1hPG levels were associated with liver fibrosis (OR = 1.99, 95% CI: 1.15–3.45, p < 0.001; OR = 2.72, 95% CI: 1.79–4.11, p < 0.001, respectively). Additionally, either 1hPG or 2hPG levels were associated with atherosclerosis, revealing significant dose-dependent associations between glucose status and atherosclerosis risk (OR = 2.77, 95% CI: 1.55–4.96, p < 0.001 for elevated 1hPG; OR = 2.98, 95% CI = 1.54–5.78, p = 0.001 for elevated 2hPG; OR = 2.41, 95% CI = 1.38–4.21, p = 0.001 for elevated levels of both 1hPG and 2hPG). The areas under the ROC for predicting steatosis, liver injury, liver fibrosis, and atherosclerosis were 0.64, 0.58, 0.58, and 0.64 for elevated 1hPG (all p < 0.05) and 0.50, 0.60, 0.56, and 0.62 for elevated 2hPG (all p < 0.05), respectively.

Conclusions

These findings underscore the necessity for clinicians to acknowledge that the screening and management of MALSD requires the monitoring of 1hPG levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseFatty LiverHumansMaleFemaleMiddle AgedRetrospective StudiesDisease ProgressionLiver CirrhosisAdultGlucose Tolerance TestRisk FactorsAgedTime FactorsBiomarkersPrediabetic State

Stichwörter der Autor:innen

alanine aminotransferaseatherosclerotic cardiovascular diseaseclinical outcomesliver fibrosisliver steatosismetabolic dysfunction-associated steatotic liver diseaseoral glucose tolerance testpost-load glucose

Substanzen

Blood GlucoseBiomarkers

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, No. 183 Huangpu East Road, Huangpu District, Guangzhou 510080, China.
  • Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
  • Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
  • Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.

ORCID-Profile: Wei Wang, Xiaopei Cao, Bihui Zhong

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Teng, L., Luo, L., Sun, Y., Wang, W., Dong, Z., Cao, X., Ye, J., & Zhong, B. (2024). Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression. Nutrients. https://doi.org/10.3390/nu17010152

Vancouver

Teng L, Luo L, Sun Y, Wang W, Dong Z, Cao X, et al. Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression. Nutrients. 2024. doi:10.3390/nu17010152

BibTeX
@article{Teng2024,
  author = {Teng, Long and Luo, Ling and Sun, Yanhong and Wang, Wei and Dong, Zhi and Cao, Xiaopei and Ye, Junzhao and Zhong, Bihui},
  title = {Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu17010152}
}
Kostenlos starten →